Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...
In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...
Interesting Engineering on MSN
Sebestyen’s theorem crosses into infinity after 40 years of mathematical limits
A classic math rule now handles infinity. New work strengthens the math behind physics and unbounded systems. % ...
Morning Overview on MSN
Ramanujan’s π equations are helping physicists decode nature
More than a century after Srinivasa Ramanujan scribbled his astonishing formulas for π in notebooks in India and England, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback